Revance Therapeutics is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in developing some of their commercial therapies and clinical analysis.
The company stated in the following article that they conduct pre-clinical trials of their drugs on animals.
“Our preclinical studies using animal models suggest that applying RT001 topically can be a potentially safe and effective treatment for the symptoms of allergic rhinitis.” (Page 10) Read the full document
Revance Therapeutics, Inc. is a clinical stage specialty biopharmaceutical company, which engages in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic, and therapeutic applications. [Source: MarketWatch]
Company Website: http://www.revance.com